How much funding has Tyra Biosciences raised?

Tyra Biosciences has raised $156.0M in total funding, most recently a Series B round.

Who are Tyra Biosciences's investors?

Tyra Biosciences's investors include Alta Partners, RA Capital Management, Canaan Partners, Boxer Capital.

When was Tyra Biosciences founded?

Tyra Biosciences was founded in 2019.

Where is Tyra Biosciences headquartered?

Tyra Biosciences is headquartered in Carlsbad, California, United States.

What industry is Tyra Biosciences in?

Tyra Biosciences operates in Biotech, Healthcare.

How many employees does Tyra Biosciences have?

Tyra Biosciences has 11-50 employees.

Tyra Biosciences

IPO

Next-Generation Precision Medicines

Public · Carlsbad, United States · Founded 2019 · $156.0M raised

Biotech

Healthcare

Headquarters: Carlsbad, California
Employees: 11–50
Founded: 2019
Business Model: B2B
Website: tyra.bio

Total Funding: $156.0M
Last Round: $106.0M Series BMar 2021
Rounds: 2
Type: Public

About

Tyra Biosciences is a clinical-stage biotechnology company developing next-generation precision medicines targeting FGFR biology and acquired resistance in oncology. Its proprietary SNÅP discovery platform enables rapid structural snapshots of drug-target interactions, accelerating structure-based drug design from weeks to days. The company has raised over $156M in financing to advance its oncology pipeline.

Summary

Tyra Biosciences is a Biotech company based in Carlsbad, United States, founded in 2019. It has raised $156.0M in total across 2 rounds, most recently a $106.0M Series B round in Mar 2021. Investors include Alta Partners, RA Capital Management and Canaan Partners.

LinkedIn X (Twitter)